Blueshift Asset Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Blueshift Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $202,811 - $233,462	-18,354 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$10.61 - $12.88 $37,410 - $45,414	-3,526 Reduced 16.12%	18,354 $231,000
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $35,066 - $45,044	-3,229 Reduced 12.86%	21,880 $255,000
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $299,299 - $349,517	25,109 New	25,109 $328,000
Q4 2020 Feb 12, 2021	SELL	$9.05 - $12.2 $242,069 - $326,325	-26,748 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $240,464 - $287,273	26,748 New	26,748 $241,000
Q3 2019 Nov 12, 2019	SELL	$8.59 - $10.96 $142,946 - $182,385	-16,641 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $163,081 - $214,502	16,641 New	16,641 $182,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $671M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.